Aldevron Plasmids Used to Support Calviri’s Clinical Trial of a Vaccine Against Canine Cancer
December 03, 2019 09:51 ET
|
Aldevron
TEMPE, A.Z. and FARGO, N.D., Dec. 03, 2019 (GLOBE NEWSWIRE) -- Prevention of cancer onset is the ultimate aspiration for animals and humans. Cancer is caused by mutations that are specific to the...
Aldevron, Nature Technology Corporation team up to offer Nanoplasmids™ for gene therapy manufacturing
October 22, 2019 07:00 ET
|
Aldevron
Fargo, N.D, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Aldevron has announced the immediate availability of Nanoplasmids™ and antibiotic-free RNA-OUT technology for use in gene therapy manufacturing. Through...
Aldevron, Nature Technology Corporation team up to offer Nanoplasmids™ for gene therapy manufacturing
October 22, 2019 01:00 ET
|
Aldevron
Fargo, N.D., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Aldevron has announced the immediate availability of Nanoplasmids™ and antibiotic-free RNA-OUT technology for use in gene therapy manufacturing....
Cytovance® Biologics Introduces an Integrated Single-use Platform for Plasmid DNA (pDNA) Manufacture
October 21, 2019 12:00 ET
|
Cytovance Biologics
OKLAHOMA CITY, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Cytovance Biologics is a leading biopharmaceutical CDMO with a 15-year track record of supplying drug substance to clients, offering fast and...
Aldevron announces GMP gene synthesis service to support neoantigen-based oncology research and other applications
October 02, 2019 11:10 ET
|
Aldevron
Fargo, ND, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Aldevron has added GMP gene synthesis to its array of services. This expanded capability will be used primarily to support Aldevron’s clients who require...
Aldevron to Build 14-Acre Gene Therapy Manufacturing Campus
June 03, 2019 06:33 ET
|
Aldevron
Fargo, N.D., June 03, 2019 (GLOBE NEWSWIRE) -- Aldevron, a leader in the production of plasmid DNA, proteins, mRNA and antibodies; announced today expansion plans for a 14-acre campus at its...
Aldevron Appoints Presidents of its Antibody and Protein Business Units, Strengthening its Position as a Global Leader in Biologics Manufacturing
May 29, 2019 10:12 ET
|
Aldevron
Fargo, ND, May 29, 2019 (GLOBE NEWSWIRE) -- Aldevron, a global leader in the custom development and manufacture of plasmid DNA, proteins, mRNA and antibodies to the biotech industry, has named...
Aldevron announces presentation of "Standardized Plasmids for Viral Vector Production" at BIO International Convention
May 23, 2019 08:00 ET
|
Aldevron
Fargo, ND, USA, May 23, 2019 (GLOBE NEWSWIRE) -- Aldevron, the leading CDMO producing plasmid DNA and other biological materials, announced today that it is scheduled to present, exhibit and conduct...
Aldevron Announces James Brown, Ph.D. as Poster Presenter and Speaker at 22nd Annual Meeting of American Society of Gene & Cell Therapy
April 25, 2019 08:52 ET
|
Aldevron
Fargo, ND, April 25, 2019 (GLOBE NEWSWIRE) -- Representatives from Aldevron, a leading contract development and manufacturing organization serving the biotech industry, will attend the 22nd Annual...